Label: NALOXONE HYDROCHLORIDE spray, metered

  • NDC Code(s): 0480-3478-19, 0480-3478-68
  • Packager: Teva Pharmaceuticals, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated January 1, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each spray)

    Naloxone hydrochloride 4 mg

  • Purpose

    Emergency treatment of opioid overdose

  • Uses

    • to “revive” someone during an overdose from many prescription pain medications or street drugs such as heroin
    • this medicine can save a life
  • Directions

    step 1

    Step 1: CHECK if you suspect an overdose:

    • CHECK for a suspected overdose: the person will not wake up or is very sleepy or not breathing well
    • yell “Wake up!”
    • shake the person gently
    • if the person is not awake, go to Step 2
     step 2

    Step 2: GIVE 1st dose in the nose

    • HOLD the nasal spray device with your thumb on the bottom of the plunger
    • INSERT the nozzle into either NOSTRIL
    • PRESS the plunger firmly to give the 1st dose
    • 1 nasal spray device contains 1 dose
     step 3

    Step 3: CALL

    • CALL 911 immediately after giving the 1st dose
     step 4

    Step 4: WATCH & GIVE

    • WAIT 2-3 minutes after the 1st dose to give the medicine time to work
    • if the person wakes up: Go to Step 5
    • if the person does not wake up:
    • CONTINUE TO GIVE doses every 2-3 minutes until the person wakes up
    • it is safe to keep giving doses
     step 5

    Step 5: STAY

    • STAY until ambulance arrives: even if the person wakes up
    • GIVE another dose if the person becomes very sleepy again
    • You may need to give all the doses in the pack
  • Warning

    • When using this product some people may experience
      symptoms when they wake up, such as, shaking, sweating,
      nausea, or feeling angry. This is to be expected.
  • Other information

    • Store below 77°F (25°C).
    • do not freeze
    • avoid excessive heat above 40°C (104°F)
    • protect from light
    • the product is packaged in individually-sealed blisters.
      Do not use if the blister is open or torn, or if the device appears damaged.
  • Inactive Ingredients

    benzalkonium chloride, edetate disodium, sodium chloride buffered with sodium hydroxide/hydrochloric acid, water

  • Questions?

    1-888-838-2872 between 9 am and 5 pm ET, Monday-Friday.
    www.tevausa.com/our-products/tevagenerics

  • SPL UNCLASSIFIED SECTION

     Safe to Use
    Even if Opioids are Not Present

    *This product is not affiliated with, manufactured by, or produced by
    the makers or owners of NARCAN®

    Manufactured For: Teva Pharmaceuticals USA, Inc.
    Parsippany, NJ 07054

    Rev. A 1/2024

  • KEEP OUT OF REACH OF CHILDREN

  • Package/Label Principal Display Panel – Carton Label

    Original Prescription Strength
    Easy to Use
    Can Save a Life

    Compare to the active
    ingredient in NARCAN®*

    NDC 0480-3478-68

    Naloxone Hydrochloride
    Nasal Spray
    4 mg

    Emergency Treatment of
    Opioid Overdose

    Designed to Rapidly Reverse the
    Effects of a Life-Threatening
    Opioid Emergency

    For use in nose only

    2 Single-Dose Nasal Spray Devices
    0.003 fl oz (0.1 mL) each

    4 mg carton
  • INGREDIENTS AND APPEARANCE
    NALOXONE HYDROCHLORIDE 
    naloxone hydrochloride spray, metered
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0480-3478
    Route of AdministrationNASAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NALOXONE HYDROCHLORIDE (UNII: F850569PQR) (NALOXONE - UNII:36B82AMQ7N) NALOXONE HYDROCHLORIDE4 mg  in 0.1 mL
    Inactive Ingredients
    Ingredient NameStrength
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    HYDROCHLORIC ACID (UNII: QTT17582CB)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0480-3478-682 in 1 CARTON09/23/2024
    1NDC:0480-3478-191 in 1 BLISTER PACK
    10.1 mL in 1 VIAL, SINGLE-DOSE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20952209/23/2024
    Labeler - Teva Pharmaceuticals, Inc. (022629579)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!